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Survivin, a newly described protein belongs to a family of proteins known as the inhibitor of apoptosis proteins (IAPs). These IAPs are crucial regulator of the molecular mechanisms involved in apoptosis. Over expression of survivin has oncogenic potential and has prognostic significance as aberrantly expressed survivin and STAT3 signalling have emerged as major determinants of chemo-resistance and more aggressive tumor and poor prognosis in cancers like stomach, [1] colon, [2] and breast. [3] Recently effect of herbal derivatives like curcumin, berberine and quercetin on STAT3 signalling, survivin expression and response to 5-fluorouracil has been studied (5-FU) treatment in gastric cancer cells (AGS). as adjunct therapeutics to overcome chemo-resistance during treatment of gastric malignancies. [4] Gupta et al. in their article in this issue have found significantly higher expression of survivin protein in gallbladder cancer as compared to non neoplastic lesions suggesting its role in gallbladder carcinogenesis. [5] Human immunodeficiency virus (HIV) infection has been prevalent for over three decades in India; an increasing number of children are being affected with HIV. The spectrum of pathologic lesions in children with acquired immunodeficiency syndrome (AIDS) in India has not been well described. The study by Lanjewar et al. provides an insight into the spectrum of pathologic lesions in children with AIDS in India. TB and CMV infection has been found to be the most prevalent infection in our children [6] Tuberculosis is one of the commonest infections encountered in India. Clinical presentation of Mycobacterium tuberculosis complex (MTBC) and non-tuberculous mycobacteria (NTM) infections may be similar but treatment is always different. [7] NTM are inherently resistant to conventional anti-tuberculosis drugs, hence often misdiagnosed as multidrug resistant tuberculosis hence, accurate differentiation between MTBC and NTM is important for proper treatment of the patients. [7] As the conventional phenotypic identification methods are cumbersome, and genotypic methods require expertise and substantial monetary and infrastructural investment, recently devised TBMPT64 antigen based immunochromatography assays offer promise in rapid and cost-effective differentiation. Nerurkar et al. in their study in this issue have tried to demonstrate in parallel the importance of assessment of a commercial MPT64 ICT and bacillary morphology on liquid culture smear, for rapid differentiation between MTBC and NTM in clinical isolates. [8] Besides this there are number of original article, interesting case reports and images that may help the young pathologists in enhancing their knowledge.
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